Stephen P Ewald sold $9.1M of MEDP
General Counsel & Corp. Secy. at Medpace Holdings, Inc.. 15,230 shares at an average of $598.85, traded Oct 27, 2025, filed Oct 29, 2025.
Score components
- +15RoleOfficer
- +25Trade size$9.1M at market
- +20Share of holdings soldSold 53% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001677297-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | MOption exercise Common Stock | +18,230 | $166.73 | $3.0M | 28,573 | Oct 29, 2025 |
| Oct 27, 2025 | SOpen-market sale Common Stock | -15,230 | $598.85 | $9.1M | 13,343 | Oct 29, 2025 |
| Oct 27, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -18,230 | $0.00 | $0 | 0 | Oct 29, 2025 |
Related signals
Other insiders at Medpace Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $30M 48,667 shares | -13% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $1.6M 2,564 shares | -1% | |
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $27M 43,916 shares | -10% | |
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $44M 70,901 shares | -14% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $6.7M 10,880 shares | -2% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $15M 24,741 shares | -5% | |
| 56Moderate | Medpace Holdings, Inc. | August J. Troendle CEO | $395k 668 shares | -0% | |
| 65Notable | Medpace Holdings, Inc. | August J. Troendle CEO | $17M 28,876 shares | -4% | |
| 65Notable | Medpace Holdings, Inc. | August J. Troendle CEO | $34M 56,482 shares | -8% | |
| 65Notable | Medpace Holdings, Inc. | Susan E Burwig Exec. VP, Operations | $12M 20,000 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.